Clinical trial
Islet of Langerhans Graft Monitoring by Magnetic Resonance Imaging
NCT00453817 · University Hospital, Geneva, Other · Terminated
Key facts
| NCT number | NCT00453817 |
|---|---|
| Title | Islet of Langerhans Graft Monitoring by Magnetic Resonance Imaging |
| Official title | Suivi Par résonance magnétique après Transplantation d'îlots de Langerhans |
| Lead sponsor | University Hospital, Geneva, Other |
| Status | Terminated |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Type 1 Diabetes Mellitus |
| Intervention type | Drug, Procedure |
| Interventions | ferucarbotran (iron-based MRI contrast agent), Islet transplantation, Magnetic resonance imaging |
| Enrollment | 5 |
| Start date | Jun 1, 2005 |
| Primary completion | Jun 1, 2010 |
| Completion | Jun 1, 2010 |
| First posted | Mar 29, 2007 |
| Last update posted | Dec 2, 2014 |
| Countries | Switzerland |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: